Expression of PPAR-γ TF by newly synthesized thiazolidine-2,4-diones to manage glycemic control: Insights from in silico, in vitro and experimental pharmacology in wistar rats

Bioorganic Chemistry, Год журнала: 2024, Номер 153, С. 107966 - 107966

Опубликована: Ноя. 17, 2024

Язык: Английский

---

Structure-Based Insights into Fatty Acid Modulation of Lipid-Sensing Nuclear Receptors PPARδ/γ for Glycemic Regulation

Aspects of Molecular Medicine, Год журнала: 2025, Номер unknown, С. 100079 - 100079

Опубликована: Март 1, 2025

Язык: Английский

---

Novel rhodanine-thiazole hybrids as potential antidiabetic agents: A structure-based drug design approach

RSC Medicinal Chemistry, Год журнала: 2024, Номер unknown

Опубликована: Ноя. 21, 2024

New rhodanine–thiazole clubbed compounds (7a–7l) were synthesised and characterised with various spectroscopy methods.

Язык: Английский

---

PPARγ modulator predictor (PGMP_v1): chemical space exploration and computational insights for enhanced type 2 diabetes mellitus management

Molecular Diversity, Год журнала: 2025, Номер unknown

Опубликована: Фев. 1, 2025

Язык: Английский

---

Design, synthesis and molecular dynamics simulations of thiazole-based hydrazones targeting MDA-MB-231 breast cancer cells

Bioorganic Chemistry, Год журнала: 2025, Номер 157, С. 108306 - 108306

Опубликована: Фев. 23, 2025

Язык: Английский

---

Novel quinoline–imidazole derivatives as inhibitors of Mycobacterium tuberculosis : an integrated approach combining molecular dynamics and in-vitro studies

Molecular Simulation, Год журнала: 2025, Номер unknown, С. 1 - 19

Опубликована: Март 14, 2025

The rationale for designing and synthesising quinoline–imidazole hybrids as antitubercular cytotoxic agents stems from the strategic combination of two bioactive structural motifs to create compounds with enhanced efficacy, dual targeting, potential overcome drug resistance challenges in tuberculosis treatment. Herein, we report design synthesis hybrids. FTIR, Mass, 1H-NMR 13C-NMR spectral data characterised synthesised compounds. These were evaluated their activity against Mycobacterium (MTB) H37Rv Hep G2, normal mouse fibroblast L929 cell lines. evaluation revealed that compound 6 g exhibited promising activities a MIC value 6.26 µg/ml, while, 6d, h 6i showed moderate MTB inhibition. Additionally, 6d demonstrated cytotoxicity HepG2 lines an IC50 46.74 ± 1.209 μg/ml. Further selected underwent theoretical investigation via molecular docking, stability assessment MD trajectories quantum computations justify experimental results. obtained predicted silico indicate act effective inhibitors.

Язык: Английский

---

Pioglitazone with SGLT2 inhibitors or GLP-1 receptor agonists in patients with type 2 diabetes and non-alcoholic fatty liver disease: could the combinations of an old friend with new players yield better outcomes?

Archives of Medical Science - Atherosclerotic Diseases, Год журнала: 2025, Номер 10(1), С. 1 - 15

Опубликована: Март 14, 2025

More than 25% of the adult population worldwide and approximately 50–75% patients with type 2 diabetes are diagnosed non-alcoholic fatty liver disease. Insulin resistance is one most crucial factors underlying its pathogenesis a significant determinant progression to steatohepatitis. The complex pathophysiology disease emphasizes need for combination treatment strategies drug classes that target different cellular pathways, since no single agent can control all mechanisms contributing development evolution. Pioglitazone, main thiazolidinedione in clinical practice, only true insulin sensitizing antidiabetic our therapeutic armamentarium diabetes. Current international practice guidelines recommend PIO as promising therapy who experience NASH GLP-1 receptor agonists SGLT2 inhibitors have shown salutary cardiometabolic renal effects diabetes, well beneficial activities those This review discusses pathophysiological background use these three categories It also explores thoroughly combinations pioglitazone either or inhibitors, their future role this setting.

Язык: Английский

---

Unleashing the potential of traditional Chinese medicine: a computational approach to discovering drug targets utilizing the CSLN and molecular dynamics

Molecular Diversity, Год журнала: 2025, Номер unknown

Опубликована: Май 3, 2025

Язык: Английский

---

Comprehensive Review on Anti-Obesity Effects of Plant-Derived Compounds: Evidence from 3T3-L1 Adipocytes and High-Fat Diet Models

Aspects of Molecular Medicine, Год журнала: 2025, Номер unknown, С. 100089 - 100089

Опубликована: Май 1, 2025

Язык: Английский

---

Cytotoxic Potential of Newly Synthesized Quinoline–Bearing Dihydropyridine Hybrids on A549 Lung Cancer Cells

Russian Journal of Bioorganic Chemistry, Год журнала: 2025, Номер 51(3), С. 1365 - 1384

Опубликована: Июнь 1, 2025

Язык: Английский

---